Virtual biotech company puts thousands of AI scientist agents to work on drug discovery - Stanford Medicine

AI agents are being deployed to speed up drug discovery in a virtual biotech company, potentially accelerating how new medicines are developed. This could eventually help patients access new treatments faster, though it's still in early stages.